Source: Biomaterials. Unidade: FMVZ
Subjects: MATRIZ EXTRACELULAR, FIBROSE PULMONAR, PROTEÔMICA, INFLAMAÇÃO, MODELOS ANIMAIS DE DOENÇAS
ABNT
LEITE, Daniele Evangelista et al. The molecular mechanisms of extracellular matrix-derived hydrogel therapy in idiopathic pulmonary fibrosis models. Biomaterials, v. 302, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.biomaterials.2023.122338. Acesso em: 29 ago. 2024.APA
Leite, D. E., Carreira, A. C. O., Nishiyama, M. Y., Gilpin, S. E., & Miglino, M. A. (2023). The molecular mechanisms of extracellular matrix-derived hydrogel therapy in idiopathic pulmonary fibrosis models. Biomaterials, 302, 1-17. doi:10.1016/j.biomaterials.2023.122338NLM
Leite DE, Carreira ACO, Nishiyama MY, Gilpin SE, Miglino MA. The molecular mechanisms of extracellular matrix-derived hydrogel therapy in idiopathic pulmonary fibrosis models [Internet]. Biomaterials. 2023 ; 302 1-17.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1016/j.biomaterials.2023.122338Vancouver
Leite DE, Carreira ACO, Nishiyama MY, Gilpin SE, Miglino MA. The molecular mechanisms of extracellular matrix-derived hydrogel therapy in idiopathic pulmonary fibrosis models [Internet]. Biomaterials. 2023 ; 302 1-17.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1016/j.biomaterials.2023.122338